Reflecting on results from four years fighting TB in the Kyrgyz Republic ...
In 2022, more than 8,000 people in the Kyrgyz Republic developed tuberculosis (TB), including
Understanding the landscape to expand, strengthen, and diversify African-based manufacturing
Poor-quality medical products are all too common in Africa, where substandard and falsified medicines kill nearly 500,000 people each year, according to the United Nations. The continent also has the highest prevalence of poor-quality medicines among low- and middle-income countries at 18.7 percent.
In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC), the national regulating authority for medical products, is prioritizing local production of medicines to ensure a safer supply of quality-assured medical products to protect patients and communities across the country and continent.
It’s been nearly 20 years since the US Pharmacopeia (USP) established our laboratories in Hyderabad and we began growing our team of scientists and other professionals in India. In the time since, the global pharmaceutical landscape has undergone a tremendous amount of evolution.
India is often referred to as the ‘pharmacy of the world’ and is undeniably the leading manufacturing hub for many of the world’s most essential medicines.
The development of generic versions of innovator medicines is a global public health need.
The issue of addressing potential nitrosamine impurities in medicines has been the focus at events taking place around the globe in recent months and will continue to do so throughout 2023.
Hundreds of global public health experts converged in late May 2023 in Geneva, Switzerland for the 76th meeting of the World Health Assembly (WHA), the decision-making body of the World Health Organization (WHO).
Substandard medicines are a huge public health threat. Proactively evaluating drug products using a relative risk assessment is important to reduce the prevalence of substandard antibiotics.